81
edits
(Created page with "The COVID-19 pandemic precipitated a global disruption of supply chains and led to significant global supply shortages in various medicines and health-related products. Shortages and struggles for access disproportionately affected vulnerable populations, including those with chronic illnesses, low-income individuals, and marginalised communities. Problems with shortages and uncertain medical stocks and reports of counterfeit medical essentials continue. Haldane, V., De...") |
|||
Line 5: | Line 5: | ||
===Ongoing Supply Chain Challenges=== | ===Ongoing Supply Chain Challenges=== | ||
Vulnerabilities in the pharmaceutical supply chain are ongoing | Vulnerabilities in the pharmaceutical supply chain are ongoing. Shortages in raw materials and logistical and manufacturing challenges contribute to ongoing, significant shortages in various drugs and supplies. | ||
'''Generic sterile injectable medications | '''Generic sterile injectable medications |
edits